Predictions
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€69.50
29.04.24
29.04.24
€100.00
31.03.26
31.03.26
-0.75%
03.05.24
03.05.24
Could be very worthwhile Investment >20% year
Agenus Inc.
Start price
Target price
Perf. (%)
€1.37
01.05.23
01.05.23
-
01.05.24
01.05.24
-69.70%
02.05.24
02.05.24
Innovative
overvalued
Risky Investment
High risks for its business
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€0.23
30.04.23
30.04.23
-
30.04.24
30.04.24
-30.34%
01.05.24
01.05.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€88.08
29.04.23
29.04.23
-
29.04.24
29.04.24
-13.03%
30.04.24
30.04.24
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€0.41
29.04.23
29.04.23
-
29.04.24
29.04.24
10.78%
30.04.24
30.04.24
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€83.00
03.03.24
03.03.24
€180.00
31.05.26
31.05.26
-16.27%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year
ImmunityBio Inc.
Start price
Target price
Perf. (%)
€2.30
29.10.23
29.10.23
€4.00
30.06.26
30.06.26
247.39%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.91
28.06.23
28.06.23
€7.00
31.01.26
31.01.26
-20.20%
28.04.24
28.04.24
Could be very worthwhile Investment >20% year
Fibrogen Inc.
Start price
Target price
Perf. (%)
€1.07
19.04.24
19.04.24
-
19.04.25
19.04.25
-10.90%
28.04.24
28.04.24
Could be very worthwhile Investment >20% year
aTyr Pharma Inc
Start price
Target price
Perf. (%)
€1.66
14.04.24
14.04.24
-
14.04.25
14.04.25
-13.86%
28.04.24
28.04.24
Could be worthwhile Investment >10% per year
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.60
25.04.24
25.04.24
-
25.04.25
25.04.25
-2.00%
27.04.24
27.04.24
Could be worthwhile Investment >10% per year
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€30.42
26.04.23
26.04.23
€72.10
26.04.24
26.04.24
-32.54%
27.04.24
27.04.24
Inotiv Inc.
Start price
Target price
Perf. (%)
€5.50
13.04.24
13.04.24
€4.00
13.04.25
13.04.25
-32.36%
27.04.24
27.04.24
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth